1-20 of 24
Sort by
News

Exploring the Potential of AI in Drug Development, Clinical Decisions

Thomas R. Collins
Published: 2023
Abstract
Mid-November 2023
View News titled, Exploring the Potential of AI in Drug Development, Clinical Decisions
News

Pulling Back the Curtain: H. Miles Prince, MD, MBBS

Mary Ellen Schneider
Published: 2022
Abstract
Mid-November 2022  In this edition, H. Miles Prince, MD, MBBS, discusses how early opportunities shaped his views on philanthropy, the promise of personalized medicine in treating blood cancers, and why it’s a great time to be a hematologist.
View News titled, Pulling Back the Curtain: H. Miles Prince, MD, MBBS
News

Blood & Beyond: Parallels Between Pandemics

Leah Lawrence
Published: 2022
Abstract
Mid-November 2022
View News titled, Blood & Beyond: Parallels Between Pandemics
News

Exploring Potential Answers for Transplantation in High-Risk Myeloid Disease

Emma Yasinski
Published: 2022
Abstract
Mid-November 2022
View News titled, Exploring Potential Answers for Transplantation in High-Risk Myeloid Disease
News

Getting Off the Seesaw: New Therapeutic Targets for Thrombosis Without Bleeding Risk

Mary Ellen Schneider
Published: 2022
Abstract
Mid-November 2022
View News titled, Getting Off the Seesaw: New Therapeutic Targets for Thrombosis Without Bleeding Risk
News

Thinking Inside the B-Cell Microenvironment Box

Katie Robinson
Published: 2022
Abstract
Mid-November 2022
View News titled, Thinking Inside the B-Cell Microenvironment Box
News

Seeking Cross-Connections in Hematology

Kimberly Retzlaff
Published: 2022
Abstract
Mid-November 2022 Interview with Scientific Program Co-Chairs Catherine J. Wu, MD, and David Bodine, PhD.
View News titled, Seeking Cross-Connections in Hematology
News

The Importance of Understanding Maternal Health in Hematology

Jill Sederstrom
Published: 2022
Abstract
Mid-November 2022
View News titled, The Importance of Understanding Maternal Health in Hematology
News

Providing Cutting-Edge, Practical Programming

Kimberly Retzlaff
Published: 2022
Abstract
Mid-November 2022 Interview with Education Program Co-Chairs David A. Garcia, MD, and Olatoyosi Odenike, MD.
View News titled, Providing Cutting-Edge, Practical Programming
News

IV Iron May Decrease RBC Transfusion Need in Chemotherapy-Induced Anemia

Katie Robinson
Published: 2022
Abstract
Mid-November 2022
View News titled, IV Iron May Decrease RBC Transfusion Need in Chemotherapy-Induced Anemia
News

Preterm Neonates Display Decreased Platelet Activation, No Increased Risk of Bleeds

Ruth Jessen Hickman, MD
Published: 2022
Abstract
Mid-November 2022
View News titled, Preterm Neonates Display Decreased Platelet Activation, No Increased Risk of Bleeds
News

Inhibition of Mutant IDH1 Stimulates AML Stem Cell Cycling

Katie Robinson
Published: 2022
Abstract
Mid-November 2022
View News titled, Inhibition of Mutant IDH1 Stimulates AML Stem Cell Cycling
News

Anticoagulants Effective for Cancer-Related VTE in Pediatric Patients

Thomas R. Collins
Published: 2022
Abstract
Mid-November 2022
View News titled, Anticoagulants Effective for Cancer-Related VTE in Pediatric Patients
News

Long-Term Data Show Value of GCSF for Severe Chronic Neutropenia

Thomas R. Collins
Published: 2022
Abstract
Mid-November 2022
View News titled, Long-Term Data Show Value of GCSF for Severe Chronic Neutropenia
News

Enasidenib Shows Durable Response in IDH2-Mutant MDS

Ruth Jessen Hickman, MD
Published: 2022
Abstract
Mid-November 2022
View News titled, Enasidenib Shows Durable Response in IDH2-Mutant MDS
News

FDA Approves Eflapegrastim-xnst for Non-Myeloid Malignancies

Published: 2022
Abstract
Mid-November 2022
View News titled, FDA Approves Eflapegrastim-xnst for Non-Myeloid Malignancies
News

Heavily Pre-Treated Patients With MM Respond to Cilta-Cel CAR T-Cell Therapy

Anna Azvolinsky, PhD
Published: 2022
Abstract
Mid-November 2022
View News titled, Heavily Pre-Treated Patients With MM Respond to Cilta-Cel CAR T-Cell Therapy
News

Priority Review Granted to Hemophilia A Treatment

Published: 2022
Abstract
Mid-November 2022
View News titled, Priority Review Granted to Hemophilia A Treatment
News

Pemigatinib Approved for R/R MLNs

Published: 2022
Abstract
Mid-November 2022
View News titled, Pemigatinib Approved for R/R MLNs
News

Pegfilgrastim Biosimilar Receives Approval for Non-Myeloid Malignancies

Published: 2022
Abstract
Mid-November 2022
View News titled, Pegfilgrastim Biosimilar Receives Approval for Non-Myeloid Malignancies